Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
Langer
Robert D
RD
D000368:Aged; D001943:Breast Neoplasms / Q000139:chemically induced* / Q000453:epidemiology; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D017698:Postmenopause; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D013997:Time Factors
D004966:Estrogens, Conjugated (USP); D017258:Medroxyprogesterone Acetate